ImmunoPrecise Antibodies (IPA)

ImmunoPrecise Antibodies (IPA) Financial Statements


ImmunoPrecise Antibodies Financial Overview

ImmunoPrecise Antibodies's market cap is currently ―. The company's EPS TTM is $-0.419; its P/E ratio is -2.29; ImmunoPrecise Antibodies is scheduled to report earnings on July 25, 2024, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Jan 24Oct 23Jul 23Apr 23Jan 23
Income Statement-
Total RevenueC$ 6.22MC$ 6.15MC$ 5.69MC$ 5.62MC$ 5.17M
Gross ProfitC$ 3.20MC$ 2.95MC$ 2.79MC$ 3.34MC$ 2.96M
EBITC$ -3.45MC$ -2.58MC$ -3.83MC$ -5.94MC$ -4.59M
EBITDAC$ -2.14MC$ -1.23MC$ -2.33MC$ -3.96MC$ -2.91M
Net Income Common StockholdersC$ -2.94MC$ -2.62MC$ -3.56MC$ -5.13MC$ -4.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 6.20MC$ 6.02MC$ 6.73MC$ 8.28MC$ 11.32M
Total AssetsC$ 78.69MC$ 75.61MC$ 76.58MC$ 77.81MC$ 82.44M
Total DebtC$ 14.39MC$ 9.57MC$ 9.81MC$ 7.27MC$ 7.47M
Net DebtC$ 8.19MC$ 3.56MC$ 3.09MC$ -1.01MC$ -3.85M
Total LiabilitiesC$ 28.87MC$ 23.58MC$ 22.74MC$ 20.01MC$ 21.36M
Stockholders EquityC$ 49.82MC$ 52.03MC$ 53.84MC$ 57.80MC$ 61.08M
Cash Flow-
Free Cash FlowC$ -501.00KC$ -534.00K-C$ -2.70MC$ -18.63M
Operating Cash FlowC$ -666.00KC$ -235.00KC$ -702.00KC$ -2.23MC$ -17.60M
Investing Cash FlowC$ 57.00KC$ -312.00KC$ -197.00KC$ -444.00KC$ -1.52M
Financing Cash FlowC$ 613.00KC$ -310.00KC$ -405.00KC$ -381.00KC$ -240.00K
Currency in CAD

ImmunoPrecise Antibodies Earnings and Revenue History

ImmunoPrecise Antibodies Debt to Assets

ImmunoPrecise Antibodies Cash Flow

ImmunoPrecise Antibodies Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis